Solid-phase parallel synthesis applied to lead optimization: Discovery of potent analogues of the GPIIb/IIIa antagonist RWJ-50042

被引：35

作者：

Hoekstra, WJ

Maryanoff, BE

AndradeGordon, P

Cohen, JH

Costanzo, MJ

Damiano, BP

Haertlein, BJ

Harris, BD

Kauffman, JA

Keane, PM

McComsey, DF

Villani, FJ

Yabut, SC

机构：

[1] R. W. Johnson Pharmaceutical Res. I., Spring House

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1996年 / 6卷 / 20期

关键词：

FIBRINOGEN; NONPEPTIDE;

D O I：

10.1016/0960-894X(96)00438-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A study of beta-turn peptide mimetics, related to the C-terminal gamma-chain of fibrinogen and containing a nipecotic acid scaffold, led to RWJ-50042 (1), an interesting fibrinogen receptor (GPIIb/IIIa) antagonist. To enhance potency, we employed solid-phase parallel synthesis for the preparation of over 200 analogues in a protocol of optimization cycles. This strategy produced several promising nipecotamide analogues, such as 25, which is 35 times more potent than 1 in vitro. Copyright (C) 1996 Elsevier Science Ltd.

引用

页码：2371 / 2376

页数：6

共 19 条

[11] Integrin receptor GPIIb/IIIa bound state conformation of the fibrinogen gamma-chain C-terminal peptide 400-411: NMR and transfer NOE studies [J].

Mayo, KH ;

Fan, F ;

Beavers, MP ;

Eckardt, A ;

Keane, P ;

Hoekstra, WJ ;

AndradeGordon, P .

BIOCHEMISTRY, 1996, 35 (14) :4434-4444

[12] RGD induces conformational transition in purified platelet integrin GPIIb/IIIa-SDS system yielding multiple binding states for fibrinogen gamma-chain C-terminal peptide [J].

Mayo, KH ;

Fan, F ;

Beavers, MP ;

Eckardt, A ;

Keane, P ;

Hoekstra, WJ ;

AndradeGordon, P .

FEBS LETTERS, 1996, 378 (01) :79-82

[13] RESOLUTION OF 1-METHYL-2-PROPYNYLAMINE VIA CHROMATOGRAPHIC-SEPARATION OF ITS DIASTEREOMERIC O-METHYLMANDELIC AMIDES [J].

NILSSON, BM ;

HACKSELL, U .

ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1988, 42 (01) :55-58

[14] A HIGHLY STEREOSELECTIVE MICHAEL ADDITION TO AN ALPHA,BETA-UNSATURATED ESTER AS THE CRUCIAL STEP IN THE SYNTHESIS OF A NOVEL BETA-AMINO ACID-CONTAINING FIBRINOGEN RECEPTOR ANTAGONIST [J].

RICO, JG ;

LINDMARK, RJ ;

ROGERS, TE ;

BOVY, PR .

JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (27) :7948-7951

[15]

RIVERO RA, 1996, IN PRESS COMBINATORI, pCH5

[16] BIOCATALYTIC APPROACH TO ENANTIOMERICALLY PURE BETA-AMINO ACIDS [J].

SOLOSHONOK, VA ;

FOKINA, NA ;

RYBAKOVA, AV ;

SHISHKINA, IP ;

GALUSHKO, SV ;

SOROCHINSKY, AE ;

KUKHAR, VP ;

SAVCHENKO, MV ;

SVEDAS, VK .

TETRAHEDRON-ASYMMETRY, 1995, 6 (07) :1601-1610

[17] Synthesis and applications of small molecule libraries [J].

Thompson, LA ;

Ellman, JA .

CHEMICAL REVIEWS, 1996, 96 (01) :555-600

[18] POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS [J].

ZABLOCKI, JA ;

RICO, JG ;

GARLAND, RB ;

ROGERS, TE ;

WILLIAMS, K ;

SCHRETZMAN, LA ;

RAO, SA ;

BOVY, PR ;

TJOENG, FS ;

LINDMARK, RJ ;

TOTH, MV ;

ZUPEC, ME ;

MCMACKINS, DE ;

ADAMS, SP ;

MIYANO, M ;

MARKOS, CS ;

MILTON, MN ;

PAULSON, S ;

HERIN, M ;

JACQMIN, P ;

NICHOLSON, NS ;

PANZERKNODLE, SG ;

HAAS, NF ;

PAGE, JD ;

SZALONY, JA ;

TAITE, BB ;

SALYERS, AK ;

KING, LW ;

CAMPION, JG ;

FEIGEN, LP .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) :2378-2394

[19]

ZABLOCKI JA, 1995, CURR PHARM DESIGN, V1, P533

← 1 2 →